NBCA/X
May 28, 2026, 23:45
NBCA Joins Global Oncology Leaders at ASCO 2026
NBCA shared a post on X:
“We’re heading to Chicago!
The National Blood Clot Alliance is proud to be exhibiting at the 2026 ASCO Annual Meeting — one of the world’s leading gatherings focused on cancer care and research — taking place May 29–June 2 in Chicago.
Cancer patients face a significantly elevated risk of blood clots, making awareness, prevention, and timely recognition a critical part of oncology care.
We’re honored to represent the patient perspective alongside leading clinicians, researchers, and advocacy organizations working to improve outcomes for patients and families impacted by cancer.
If you’re attending ASCO 2026, stop by the patient advocacy area and visit our booth — we’d love to connect!”
Stay updated with Hemostasis Today.
-
May 28, 2026, 17:42Nagendra Sungala: International Clinical Trials Day Validates the Work of Our Hematology Clinical Trials Unit
-
May 28, 2026, 17:41Thomas Pincez: Looking for Great Contributions on Pediatric Hematology
-
May 28, 2026, 17:40Masoabi Sefojane: The Real Cost of a Bleeding Disorder Is More Than Cost Alone
-
May 28, 2026, 17:39Zeyad Kholeif: New Publication on Rapid Plaque Progression Leading to STEMI in a Young Athlete
-
May 28, 2026, 17:39Karina Althaus: Results of the SSC Subcommittee International Survey on HIT
-
May 28, 2026, 16:45Thrilled to Present The ISTH Roberts Award to Donald Arnold – ISTH
-
May 28, 2026, 16:36Connor Webb: IL-6 as a Primer of Platelet Hyperresponsiveness
-
May 28, 2026, 16:19James Farrell: The Power of Linked Electronic Health Records for Understanding Real Patient Journeys
-
May 28, 2026, 16:19Michael Makris: I Hope The Bleeding Disorders Community Supports Kedrion Initiative for FV Deficiency